Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

University of Athens, University of California patent PLA2 inhibitors

Aug. 30, 2016

Trillium Therapeutics discovers bromodomain-containing protein inhibitors

Aug. 29, 2016

Sorrento Therapeutics discloses anti-HER2 antibody-dolastatin derivative conjugates

Aug. 29, 2016

Ginkgo Pharmaceutical describes novel nucleoside derivatives

Aug. 29, 2016

Sage Therapeutics patents GABA (A) receptor modulators

Aug. 29, 2016

Piramal Enterprises discloses GPR120 agonists

Aug. 29, 2016

Sorrento Therapeutics discloses anti-HER2 antibody-anthracycline conjugates

Aug. 26, 2016

Rugen Holdings reports NR2B receptor antagonists

Aug. 26, 2016

Cancer Research Technology announces ENPP2 inhibitors

Aug. 26, 2016

AbbVie reports SUV420H1 inhibitors

Aug. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...